Antifungal Drug

Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).

The fight against black fungus is getting tough due to the shortage of an antifungal drug Amphotericin B.

The government is engaging with drug manufacturers to ramp up the production of an antifungal drug used for the treatment of mucormycosis, the Chemicals and Fertilizers Ministry said.

This method, which is based on essential oils, can also reduce the risk of inducing drug resistance in the fungus and it can also counter those fungi that have developed resistance to conventional antifungal drugs.

Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).

The fight against black fungus is getting tough due to the shortage of an antifungal drug Amphotericin B.

The government is engaging with drug manufacturers to ramp up the production of an antifungal drug used for the treatment of mucormycosis, the Chemicals and Fertilizers Ministry said.

This method, which is based on essential oils, can also reduce the risk of inducing drug resistance in the fungus and it can also counter those fungi that have developed resistance to conventional antifungal drugs.